Association between insulin resistance, lean mass and muscle torque/force in proximal versus distal body parts in healthy young men by Gysel, Tineke et al.
41
Introduction
Type 2 diabetes mellitus (T2DM) is a major health problem,
and is commonly associated with cardiovascular disease, neu-
ropathy, retinopathy and nephropathy. Skeletal muscle disease
or ‘myopathy’, is a much less studied complication of T2DM. 
Diabetes has been associated with an increased prevalence
of sarcopenia1 and with an accelerated reduction of skeletal
muscle mass percentage of total body weight as well as muscle
weakness2,3, both especially in the lower extremity4. In T2DM
patients, insulin resistance is negatively associated with knee
extension force divided by body weight5. According to Sun
and colleagues6, it is the impaired insulin action (or insulin re-
sistance) in the skeletal muscle that underpins the diverse
metabolic, structural and functional changes in the skeletal
muscle of T2DM patients.
Insulin resistance (IR) in the skeletal muscle is due to an ac-
cumulation of intracellular lipid metabolites. They indirectly
inhibit insulin-stimulated glucose transport into the cell
(GLUT 4 - glucose transporter 4- activity)7. Thus, the impaired
response of muscle to insulin, is a consequence of the meta-
bolic impact of increasing obesity and fat deposition in hu-
mans8. Insulin resistance (IR) is a pathophysiological stage that
precedes T2DM9. In this stage, the pancreas compensates this
lower insulin-effectiveness by increasing the insulin secretion
in order to maintain normal blood glucose levels. Once the
beta cell function fails to maintain glucose control, impaired
glucose tolerance and diabetes mellitus are the consequences10.
Recently, increasing research effort has been focusing on the
relation between insulin resistance and muscle function/physi-
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cal function in people without diabetes. However, data on this
matter are still scarce.
Previous studies in non-diabetics tended to focus on insulin
resistance in elderly. In this older, non-diabetic group, insulin
resistance is associated with lower quadriceps torque per kilo-
gram lean mass11, and with lower gait speed but not with lower
absolute peak leg force12. 
Recent studies suggest that there is a dramatic increase in
T2DM among individuals in their thirties, whereas in the past,
T2DM usually manifested in the late sixties of susceptible in-
dividuals13. Since IR is apparent approximately 10 years earlier
than T2DM14, it may be presumed that, also IR might have an
earlier onset nowadays, what also might be associated with an
earlier decrease of muscle mass and force/torque. We hypoth-
esized that relative muscle mass, estimated by lean mass per-
centage (of total body weight or total lean mass) and relative
muscle force/torque would decrease with a decrease in insulin
sensitivity, estimated by HOMA index (Homeostasis Model
Assessment of Insulin Resistance), even in a young healthy
population.
To the best of our knowledge, only two authors focused on
a (young) adult population. Unni et al.15 have shown that re-
duced insulin sensitivity in healthy adult men (18-34 years) is
associated with reduced relative lean mass and reduced stan-
dardized handgrip force (expressed as maximal voluntary con-
traction divided by forearm muscle area). Srikanthan &
Karlamangla16 confirmed an inverse relationship between in-
sulin resistance and relative muscle mass (the ratio of esti-
mated skeletal muscle mass to total body weight, expressed as
a percentage) in an adult population (31-58 years) of people
with and without diabetes, and this association persisted when
people with diabetes were excluded from the analytic sample. 
Although some of the above cited studies have only studied
the effect of IR on muscles in lower limbs, they often general-
ize the resulting effects of IR to the upper and lower limbs. In
some studies the determination of muscle force or torque was
restricted to the upper extremities. Unni and colleagues15 for
instance, only assessed handgrip force. According to Olsen et
al.17 glucose clearance may not be evenly distributed through-
out the muscles of the whole body. In people with diabetes,
glucose clearance in leg muscles is lower than in arm muscles,
because of a better preserved insulin sensitivity in arm mus-
cles17. According to Andersen et al.4, muscle torque loss in di-
abetes seems larger in distal muscles compared to proximal
muscles. This may be related to the presence and severity of
peripheral neuropathy4. Peripheral neuropathy can already be
present in people with impaired glucose tolerance not having
diabetes18,19. We hypothesized that, in a population without di-
abetes, insulin resistance would have a larger influence on dis-
tal muscle characteristics (like muscle mass, muscle torque and
muscle force) compared to proximal muscles.
To test our hypotheses, we compared thigh-, lower leg-,
upper arm- and forearm lean mass (as a surrogate for skeletal
muscle mass), as well as muscle performance (torque of
elbow- and knee flexor/extensor and handgrip force) of a more
insulin sensitive (MIS) group with a less insulin sensitive
group (LIS) of healthy young men. As far as we know, this is
the first study that measures both upper and lower body muscle
torque and compares distal and proximal muscle volumes in a
young healthy population. 
Materials and methods
Subjects
The population for this study was selected (using upper and
lower quartiles of HOMA index) from a group of 358 young
unrelated healthy adult men who were, in turn, randomly se-
lected, choosing one brother out of a sibling-pair study20 which
included 276 pairs, 17 triplets, two quartets of dizygotic broth-
ers, and 63 single participants. These men, aged 24 to 45 years,
were recruited from population lists of semirural communities
around Ghent (Belgium). Exclusion criteria were illnesses or
medication use that may affect body composition, bone me-
tabolism or sex steroid levels. All men were in good health and
completed questionnaires about previous illness and smoking.
Subjects were not excluded based on weight, risk factors for
diabetes or daily exercise level. Subjects with diabetes (HbA1c
measured in a fasting blood sample ≥6,5% or 48 mmol/mol21)
were excluded from the present study.
The study was approved by the Ethical Committee of the
Ghent University Hospital and was performed in accordance
with the Declaration of Helsinki. All participants gave their
written informed consent.
Measurements of muscle –mass 
To determine lean mass and fat mass of the dominant upper
and lower extremity, all participants underwent total-body dual-
energy X-ray absorptiometry (DEXA) using a Hologic QDR
4500 DXA Discovery AU device, Hologic Inc., Bedford, MA,
USA). Appendicular muscle mass (kg) was determined assum-
ing that lean mass (= non-fat and non-bone tissue) would be
skeletal muscle22. Thighs were defined as all tissue between a
diagonal line drawn through and perpendicular to the axis of the
femoral neck (angled with the pelvic brim) and a horizontal line
drawn through the interarticular space of the knee. Lower legs
were defined as all tissue beneath this horizontal line. Upper
arms were defined as the tissue extending from the center of the
arm socket to the interarticular space of the elbow and forearms
were defined as all tissue extending from this interarticular space
to the phalange tips. This procedure is based on the procedure
of Kim et al. (2002) that has been validated against measure-
ments with Magnetic Resonance Imaging22. Thigh-, lower leg-
, upper arm- and forearm muscle mass are given in absolute
mass and were also calculated as percentage of body weight.
Measurement of muscle torque
The torque of knee- and elbow- flexors and extensors (large
muscle groups) was assessed using an isokinetic dynamometer
(Biodex Corporation, New York, NY, USA) at the dominant
limbs. The muscle contractions were performed at a preset
constant angular velocity of 180°/sec. For each condition three
trial-efforts and five maximal efforts were allowed to produce
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five overlying curves. The subjects were verbally encouraged
to exert maximal efforts and a 60-second rest period was pro-
vided between each condition. The peak torque was recorded
in Newton meters and used for the analysis. Isokinetic data
were presented as absolute values (Nm) and relative values
were calculated by taking the ratio of torque to the correspon-
ding (upper arm- or thigh-) lean mass measured by DEXA. 
Measurement of muscle force
A calibrated, Jamar dynamometer (Smith and Nephew, Ir-
wington, NY 10533, USA) was used to assess hand grip force
at the dominant hand (representing a smaller and more distal
muscle group in the upper extremity). Three measurements of
each grip were obtained at 15s intervals (preceded by two trial-
efforts) and mean values were used in the analysis. The %CV
(percent coefficient of variation) for the measurement was
16,3%. Next to the measured absolute values (in kg), relative
values (the ratio of hand grip force (kg) to the corresponding
forearm lean mass measured by DEXA) were calculated. 
Measures of insulin resistance
Fasting plasma glucose and insulin concentrations were
measured in a morning blood sample (before 10 am). The
HOMA-IR index (Homeostasis Model Assessment of Insulin
Resistance) was calculated as [fasting serum insulin (mU/l) *
fasting plasma glucose (mmol/l)/22.5], with higher values in-
dicating a higher degree of insulin resistance23. By using lower
and upper quartiles24 of IR, the more insulin sensitive group
had HOMA-indices of ≤0.96 and the less insulin sensitive
group had HOMA-indices of ≥2.09. The cut-off value, used in
literature, to identify individuals as being “insulin resistant”,
varies widely (from the 75th percentile25-27 to the 90th per-
centile28,29), that’s why we use the term “less insulin sensitive
subjects” instead of “insulin resistant subjects”. Glucose (hex-
okinase method) and insulin concentrations were determined
on a Modular P and E respectively using Roche Diagnostics
consumables (Roche Diagnostics, Mannheim, Germany). 
Covariates
Standing height and weight were obtained from each par-
ticipant, and body mass index (BMI) was calculated. Age of
participants was determined to the nearest year. The ‘Baecke
questionnaire’ was used to determine levels of physical activ-
ity. Cumulative exposure to cigarette smoking was summa-
rized by multiplying the average number of packs smoked per
day (cigarettes smoked per day divided by 20) by the number
of years smoked (pack years of smoking), regardless of
whether smoking status was former or current. 
Statistical data analysis
Descriptive statistics are reported as means ± SD (only the
present smoking status is reported in %). To compare the sub-
ject characteristics, independent t-tests for means were used
for comparing continuous variables, the chi-square test was
used to compare categorical variables. Since age and physical
activity can influence muscle mass and force/torque, (and be-
cause we are interested in the extra influence of IR on
mass/force/torque, on top of the influence of age and physical
activity), they were controlled for in subsequent analyses. Lean
mass (as a surrogate for muscle mass) is not only displayed in
absolute numbers, but also relative to body weight. Muscle
mass in its turn determines muscle force and torque, therefore
force and torque parameters were expressed both in absolute
numbers and relative to the corresponding muscle mass. Sta-
tistical analysis between the groups in the upper and lower
quartile for insulin resistance were assessed using univariate
analysis of covariance (ANCOVA), correcting for age and
level of physical activity (they were entered as covariates). All
of the analyses were performed using SPSS software version
19.0.0 for Windows (Statistical Package for the Social Sci-
More insulin sensitive (n=89) Less insulin sensitive (n=89) P-value
Age (years) 33.2±5.4 35.6±5.3 0.003*
Height (m) 1.80±6.18 1.79±6.57 0.521
Body weight (kg) 76.0±8.18 91.0±13.7 <0.001*
Body Mass Index (kg/m2) 23.4±3.3 28.2±3.9 <0.001*
Fat mass (kg) 12.6±4.5 21.7±7.1 <0.001*
Lean mass % of Total body weight 83.7±0.5 77.0±0.5 <0.001*
Lean mass (kg) 63.6±5.9 68.9±7.5 <0.001*
Physical activity (score/15) 8.65±1.41 7.98±1.39 0.002*
Pack years 4.36±7.65 5.80±9.06 0.256
Smoking(%)
- Yes 24.7 25.8
- No 75.3 74.2 0.500
*significant difference between groups (p<0.05).
Table a. Characteristics of the subjects. Age, anthropometric data, body composition, physical activity and smoking habits in the two subject
groups. (Values are means ± Standard Deviations, only the present smoking status is reported in %).
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ences Inc., Chicago, IL, USA) and statistical significance was
assumed at P<0.05.
Results
Among the 358 healthy adult men, the 89 subjects in the
lower quartile for insulin resistance had HOMA indices of
≤0.96 and formed the more insulin sensitive (MIS) group, the
89 subjects in the upper quartile (HOMA ≥2.09) formed the
less insulin sensitive (LIS) group. Descriptive characteristics
of the groups are presented in Table a. The LIS group was older,
had greater body mass, fat mass, BMI, lower lean mass % of
total body weight and reported less physical activity (p<0.05,
each) than their more insulin sensitive (MIS) counterparts.
There was no difference in smoking habits between the two
groups (not in pack years, not in present smoking status).
The LIS subjects had significantly higher upper arm and
thigh (more proximal body parts) lean mass (estimated by
DEXA) than their MIS counterparts (relative difference of re-
spectively 11.8% and 8.8%, both p<0.001) (Table b). In fore-
arm and lower leg (more distal body parts) the LIS subjects
also tended to have more absolute lean mass (respectively
3.6% and 2.4%), however, this difference was not statistically
significant (p=0.074 and p=0.102, respectively). 
When expressing lean mass in different body parts relative
to total body weight, LIS subjects had lower appendicular lean
mass percentage of total body weight when compared to the
MIS individuals, with a relative difference of -14% in lower
leg (p<0.001), followed by a relative difference of -12.3% in
forearm (p<0.001), -8.1% in thigh (p<0.001) and -4.9% in
upper arm (p=0.023) (Table b).
When expressing lean mass in the different body parts rel-
ative to total lean mass, LIS subjects had lower values in the
most distal body parts, with a relative difference of -5.7%
(p<0.001) in lower leg and -4.3% (p=0.001) in forearm. In the
more proximal body parts, LIS subjects show higher values,
with a relative difference of 0.8% in thigh and 3.7% in upper
arm (Table b).
Table c presents the comparison of absolute handgrip force
(representing forearm muscles) and absolute knee and elbow
flexor/extensor torque between the 89 LIS and 89 MIS subjects.
These data show that the LIS subjects had a significantly higher
elbow extension torque (8%, p<0.05) and borderline signifi-
cantly higher elbow flexion torque (5%, p=0.083) than the MIS
group. LIS subjects did not show higher values for the isoki-
netic knee flexion/extension torque. For absolute handgrip
force, both groups showed almost identical mean values. 
Table d presents the comparison of muscle torque or –force,
normalized to the corresponding lean mass. Isometric handgrip
force, normalized to forearm lean mass, has been found to be
significantly lower in LIS individuals compared to the MIS
group (-5.5%, p<0.005). Considering the relative isokinetic
data, knee flexion and extension torque, normalized to thigh
lean mass also seems lower in the LIS group (with a difference
of -10.3%, p<0.05 and -7.3%, p<0.05, respectively). In upper
arm, the relative elbow flexion torque (but not the relative
elbow extension torque) seems lower in the LIS group (a dif-
ference of -7.6%, p<0.05). 
All these results are independent of the fact that the LIS
group is older and reported less physical activity.
More insulin sensitive Less insulin sensitive P-value Relative ∆ (%)
(n=89) (n=89)
Absolute lean mass (kg)
Upper arm 2.337±0.342 2.649±0.430 <0.001* 11.8%
Forearm 1.475±0.188 1.531±0.199 0.074 3.6%
Thigh 7.047±0.814 7.728±1.049 <0.001* 8.8%
Lower leg 3.359±0.377 3.439±0.448 0.102 2.4%
Relative lean mass 
(% of total body weight)
Upper arm 3.08±0.340 2.93±0.358 0.023* -4.9%
Forearm 1.95±0.219 1.71±0.239 <0.001* -12.3%
Thigh 9.29±0.687 8.54±0.686 <0.001* -8.1%
Lower leg 4.44±0.432 3.82±0.428 <0.001* -14%
Relative lean mass 
(% of total lean mass)
Upper arm 3.67±0.343 3.81±0.358 0.004* 3.7%
Forearm 2.31±0.205 2.21±0.217 0.001* -4.3%
Thigh 11.06±0.544 11.15±0.635 0.048* 0.8%
Lower leg 5.28±0.369 4.98±0.362 <0.001* -5.7%
*significant difference between groups (p<0.05), p-values are from age- & physical activity adjusted ANCOVA, comparing MIS and LIS subjects. 
Table b. Comparison of absolute and relative lean mass (using DEXA) in dominant upper and lower limbs between MIS and LIS subjects.
(Values are means ± Standard Deviations).
T. Gysel et al.: Insulin resistance & muscle in non-diabetics
45
Discussion
One of the main findings of the present study was that LIS
adults did not only have more body mass and more fat mass,
but they also have been found to have larger absolute upper
arm and thigh muscle mass than the MIS adults. Obese persons
usually have more absolute muscle mass30 (as well as subjects
with lower insulin sensitivity31) and more absolute torque or
force than non-obese persons32,33. As an explanation, many re-
searchers have suggested that the extra weight chronically car-
ried by obese individuals might serve as a favorable training
stimulus to increase muscle mass34. Unlike muscle mass in
upper arm and thigh, muscle mass in forearm and lower leg
(more distal body parts) were not statistically higher in the LIS
group, there was only a borderline significance (respectively
p=0.074 and p=0.102), possibly indicating a more pronounced
negative influence of insulin resistance in the more distal body
parts (in turn, lowering muscle mass). When body weight was
taken into account, a higher fat and lower muscle mass per-
centage of total body weight was found in the LIS group (both
in arms and legs). This is in line with previous findings of Unni
et al.15 and Srikanthan & Karlamangla16 also focusing on an
adult population. As hypothesized, insulin resistance in the
present young healthy population, is associated with lower
muscle mass percentage respective to total body weight (as a
consequence of the higher fat mass percentage) and higher ab-
solute muscle mass in proximal body parts. The largest differ-
ences (between the 2 groups) in lean mass percentage of total
body weight, were seen in lower leg (with a relative difference
of -14%), followed by forearm (-12.3%), thigh (-8.1%) and fi-
nally upper arm (-4.9%). When total lean mass was taken into
account, a lower percentage of total lean mass was found in
the most distal body parts of the LIS group (-5.7% in lower
leg and -4.3% in forearm), indicating a different muscle mass
More insulin sensitive Less insulin sensitive P-value Relative ∆ (%)
(n=89) (n=89)
Absolute Peak Torque (Nm) 
Upper arm
- Elbow flexion 40.3±9.4 42.2±9.2 0.083 5.0%
- Elbow extension 32.2±6.7 35.0±8.5 0.008* 8.0%
Absolute Peak Torque (Nm) Thigh 
- Knee flexion 72.3±17.3 71.1±20.2 0.750 -1.7%
- Knee extension 137.9±26.5 141.2±36.7 0.363 2.3%
Absolute handgrip force (kg)
(forearm) 52.9±9.29 51.7±7.66 0.266 -2.3%
*significant difference between groups (p<0.05), p-values are from age- & physical activity adjusted ANCOVA, comparing MIS and LIS subjects.
Table c. Comparison of absolute muscle torque and -force in dominant upper and lower extremity between MIS and LIS subjects. (Values are
means ± Standard Deviations).
More insulin sensitive Less insulin sensitive P-value Relative ∆ (%)
(n=89) (n=89)
Peak Torque / upper arm lean mass 
(Nm/kg)
- Flexion 17.25±3.32 15.94±2.85 0.022* -7.6%
- Extension 13.83±2.32 13.27±2.62 0.229 -4.0%
Peak Torque / Thigh lean mass 
(Nm/kg)
- Flexion 10.22±1.90 9.17±2.35 0.012* -10.3%
- Extension 19.64±3.37 18.20±4.18 0.017* -7.3%
Handgrip force / forearm lean mass 
(kg/kg) 35.93±4.56 33.97±4.41 0.003* -5.5%
*significant difference between groups (p<0.05), p-values are from age- & physical activity adjusted ANCOVA, comparing MIS and LIS subjects.
Table d. Comparison of relative muscle torque and -force in dominant upper and lower extremity between MIS and LIS subjects. (Values are
means ± Standard Deviations).
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distribution (in contrast to the previous parameter: muscle
mass % of total body weight, which can be a result of a differ-
ent fat distribution in large part). In the more proximal body
parts, LIS subjects show higher muscle mass percentages of
total lean mass (0.8% in thigh and 3.7% in upper arm). This
fits with our hypothesis that insulin resistance is associated
with lower relative muscle mass in the most distal body parts.
We don’t have any data on neuropathy in this healthy co-
hort, but finding similar results in relative muscle mass of peo-
ple with a higher chance developing diabetes, this distribution
could possibly indicate an early onset of distal neuropathic
processes in these healthy individuals with lower insulin sen-
sitivity. The development of neuropathy in diabetes mellitus
takes time and there are arguments that support the direct ac-
tion of insulin resistance on the pathogenesis of neuropathy.
Hyperinsulinemia (a compensatory response to IR) has been
reported to cause neuropathic changes35, and neurons can also
become ‘insulin resistant’36. According to Sumner et al. (2003),
peripheral neuropathy can already be present in people without
diabetes but with an impaired glucose tolerance (IGT). Ziegler
et al. also found a slightly increased prevalence of polyneu-
ropathy in individuals with IGT and impaired fasting glucose
(IFG). Distal symmetric polyneuropathy is the most common
variety of neuropathy. The nerve fibers are affected in a length-
dependent pattern; feet and lower leg are affected first, fol-
lowed by hands, and later on, more proximal body parts such
as thighs are influenced37. 
Isokinetic data demonstrated that, in general, LIS subjects
had significantly higher absolute elbow flexion/extension
torque than their MIS counterparts, in accordance with the
larger absolute amounts of upper-arm lean mass. But surpris-
ingly, LIS subjects, in general, did not show significantly higher
absolute knee flexion/extension torque in lower limbs, despite
their larger absolute thigh lean mass. This finding supports pre-
vious research in non-diabetic elderly11,12. Kuo et al. noted that
HOMA-IR is not associated with absolute peak knee extensor
force12. Barzilay et al., found a significant positive association
of absolute quadriceps lean mass with HOMA-IR, and did not
find a significant association between absolute quadriceps
torque and HOMA-IR11. This lower efficacy, found in thigh,
but not necessarily in elbow muscles, was confirmed in our
study by a lower relative thigh muscle torque (knee flexion and
extension torque, normalized to thigh lean mass) in LIS adults
compared to their MIS counterparts. 
Muscle torque or force is determined by the available ab-
solute muscle mass, the muscle density (which is a measure of
fat infiltration in the muscle organ envelope), the blood flow to
the muscle, the metabolic capacity of the muscle fibers (mean-
ing: fiber type, the number of mitochondria and mitochondrial
efficiency in the muscle fibers), and the degree of activation
(nerve control). Muscle quantity is higher in the LIS group, but
thigh torque is not higher. This lower efficacy in thigh muscles
could therefore be due to higher fat infiltration in the muscle,
lower blood flow to the muscle fibers, lower metabolic capacity
of the fibers and/or a loss in degree of muscle activation (a po-
tential nerve function decline). Several authors have shown that
insulin resistance in a healthy population is associated with
lower muscle density as measured with CT, indicating higher
fat infiltration in thigh muscles38,39. Goodpaster et al.40 showed
that lower quadriceps density can indeed account for differ-
ences in muscle torque not attributed to muscle quantity. Sub-
jects in an insulin resistant state seem to have a higher degree
of sympathetic activation than age-matched insulin sensitive
subjects41. This sympathetic overactivity would partly be
caused by hyperinsulinemia42 in this group. It can produce
vasoconstriction and can diminish the regional blood flow and
tissue glucose delivery42,43. The impaired hemodynamic effect
of insulin to facilitate access to the muscle cells for nutrients
may manifests (in chronic situations) as a decreased capillary
density of muscle44, enlarging the diffusion distance in IR in-
dividuals45. Activation of adrenergic peripheral ß-receptors also
changes proportion between slow and fast twitch muscle
fibers46. The inability to modify fuel oxidation in response to
changes in nutrient availability has been implicated in the ac-
cumulation of intramyocellular lipid and insulin resistance47.
This reduced ability to switch from fat to carbohydrate oxida-
tion is called “metabolic inflexibility”. IR causes metabolic dis-
turbance characterized by reduced cellular glucose uptake and
fatty acid oxidation, leading to an augmented lipid deposition
and oxidative stress, in turn associated with a reduced mito-
chondrial density6 and function48 in skeletal muscle tissue. We
don’t have any data on thigh nerve function in this healthy co-
hort, but Oltman et al.49 found a sciatic neural dysfunction in
non-diabetic rats with an impaired glucose tolerance. They had
a lower motor nerve conduction velocity and lower endoneur-
ial blood flow in sciatic nerve compared with age-matched
lean control rats. Thigh nerve dysfunction in insulin resistant
subjects, still has to be demonstrated in humans. Adding an
EMG to assess amplitude and nerve conduction velocity of dif-
ferent nerves may have an added value in future research. The
lower thigh muscle efficacy could thus possibly be the result
of the combination of lower thigh muscle density, blood flow,
metabolic capacity and/or thigh nerve function decline.
Since not only upper arm lean mass is higher, but also upper
arm muscle torque is generally higher and lower relative
torque values are only found in the LIS group for elbow flex-
ion, but not for elbow extension, we can conclude that the
lower efficacy is definitely less pronounced in upper arm mus-
cles, when compared to thigh muscles. A potential explanation
for lower relative torque values in elbow flexion, but not ex-
tension could be the following. IR mainly targets type 1 muscle
fibers50,51. In general, elbow extensors (triceps brachii) have a
higher percentage of type 2 muscle fibers than the elbow flex-
ors (biceps brachii)52,53, what makes those extensor muscles
‘less susceptible’ for insulin resistance. 
In our study, isometric data of a more distal part of the upper
limb showed that both groups had almost identical mean val-
ues for absolute hand grip force (while there was a trend for
larger forearm muscle mass in LIS subjects), possibly suggest-
ing a lower muscle efficacy in forearm. This is confirmed in
our study by the significantly lower handgrip force per kg lean
forearm mass in LIS individuals. In 2009, Unni et al.15 found
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a positive significant association between insulin sensitivity
and handgrip force divided by forearm muscle area, analogous
to our results. We can conclude that the lower efficacy is more
pronounced in forearm muscles, when compared to upper arm
muscles. And just like in thigh muscles, the lower forearm
muscle efficacy could possibly be the result of a combined
lower forearm muscle density, blood flow, metabolic capacity
and/or a nerve function decline in the distal upper limb. 
Our study has several limitations. First, we did not measure
muscle torque or force in the lower leg, while this might have
supported our conclusions on the differential influence of in-
sulin resistance in proximal versus distal body parts. Second,
we acknowledge that this cross-sectional study examines only
associations between IR and muscle mass/force/torque. These
associations neither can prove causality nor define the manner
in which they are related. The association of IR and relative
muscle mass/force/torque could simply be epiphenomena of
changes in muscle physiology54, or it may be a vicious cycle.
For example, it is possible that a lowered relative muscle
mass/force/torque may lead to lowered physical activity, a pos-
itive energy balance, greater deposition of intramuscular lipid,
more IR and in turn further lowering of muscle force/torque.
Hence, the relationship between muscle force/torque and in-
sulin sensitivity is difficult to explain in terms of cause and ef-
fect and should be prospectively explored. 
In conclusion, despite these limitations, this study puts for-
ward that, even in a young non-diabetic population, insulin re-
sistance is associated with lower muscle mass relative to total
mass and lower muscle force/torque relative to muscle mass
(just like in non-diabetic elderly11), and this can predominantly
be seen in distal body parts (just like in diabetes4). Early de-
tection and reduction of IR and its risk factors may also con-
tribute to preserving muscle function next to preventing the
evolution towards type 2 diabetes mellitus.
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